University of Nebraska Medical Center, Omaha, NE, discusses the phase 3 CheckMate 067 trial of nivolumab alone or combined with ipilimumab versus ipilimumab alone in treatment-naive patients with advanced melanoma.
Join our mailing list
To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now